The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genome-wide association study for identification of candidate SNPs associated with carboplatin and paclitaxel clearance in ovarian cancer patients.
Bo Gao
No relevant relationships to disclose
Yi Lu
No relevant relationships to disclose
Annemieke J.M. Nieuweboer
No relevant relationships to disclose
Hongmei Xu
Employment or Leadership Position - AstraZeneca (U)
Jonathan Beesley
No relevant relationships to disclose
Inge M. Ghobadi Moghaddam-Helmantel
No relevant relationships to disclose
Anne-Joy M. de Graan
No relevant relationships to disclose
Peter de Bruijn
No relevant relationships to disclose
Howard Gurney
No relevant relationships to disclose
Sharon Johnatty
No relevant relationships to disclose
Philip James Beale
No relevant relationships to disclose
Ron H.J. Mathijssen
No relevant relationships to disclose
Paul R. Harnett
No relevant relationships to disclose
Rosemary L Balleine
No relevant relationships to disclose
Georgia Chenevix-Trench
No relevant relationships to disclose
Stuart MacGregor
No relevant relationships to disclose
Anna deFazio
No relevant relationships to disclose